These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2123870)

  • 1. Restoration of serine protease-inhibitor interaction by protein engineering.
    Madison EL; Goldsmith EJ; Gething MJ; Sambrook JF; Gerard RD
    J Biol Chem; 1990 Dec; 265(35):21423-6. PubMed ID: 2123870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1.
    Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF; Bassel-Duby RS
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3530-3. PubMed ID: 2110366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective screening of a large phage display library of plasminogen activator inhibitor 1 mutants to localize interaction sites with either thrombin or the variable region 1 of tissue-type plasminogen activator.
    van Meijer M; Roelofs Y; Neels J; Horrevoets AJ; van Zonneveld AJ; Pannekoek H
    J Biol Chem; 1996 Mar; 271(13):7423-8. PubMed ID: 8631768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the one-chain to two-chain conversion in tissue plasminogen activator: characterization of mutations at position 275.
    Higgins DL; Lamb MC; Young SL; Powers DB; Anderson S
    Thromb Res; 1990 Feb; 57(4):527-39. PubMed ID: 2139248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serpin-resistant mutants of human tissue-type plasminogen activator.
    Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF
    Nature; 1989 Jun; 339(6227):721-4. PubMed ID: 2500599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.
    Keijer J; Ehrlich HJ; Linders M; Preissner KT; Pannekoek H
    J Biol Chem; 1991 Jun; 266(16):10700-7. PubMed ID: 1709939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator.
    Declerck PJ; De Mol M; Vaughan DE; Collen D
    J Biol Chem; 1992 Jun; 267(17):11693-6. PubMed ID: 1601844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activation of plasminogen by T-PA-PAI-1 complex in the absence of fibrin.
    Takada Y; Takada A
    Thromb Res; 1991 Jul; 63(1):169-77. PubMed ID: 1835180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants of tissue-type plasminogen activator that display extraordinary resistance to inhibition by the serpin plasminogen activator inhibitor type 1.
    Tachias K; Madison EL
    J Biol Chem; 1997 Jun; 272(23):14580-5. PubMed ID: 9169416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells.
    Morton PA; Owensby DA; Wun TC; Billadello JJ; Schwartz AL
    J Biol Chem; 1990 Aug; 265(24):14093-9. PubMed ID: 2167306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers.
    Ramakrishnan V; Sinicropi DV; Dere R; Darbonne WC; Bechtol KB; Baker JB
    J Biol Chem; 1990 Feb; 265(5):2755-62. PubMed ID: 2105933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator.
    Orth K; Willnow T; Herz J; Gething MJ; Sambrook J
    J Biol Chem; 1994 Aug; 269(33):21117-22. PubMed ID: 8063731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome].
    Fukao H; Yamamoto K; Matsuo O
    Rinsho Byori; 1991 Jul; 39(7):720-6. PubMed ID: 1920864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexing of tissue plasminogen activator with PAI-1, alpha 2-macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor.
    Bennett B; Croll A; Ferguson K; Booth NA
    Blood; 1990 Feb; 75(3):671-6. PubMed ID: 1688722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational and immunochemical analysis of plasminogen activator inhibitor 1.
    Shubeita HE; Cottey TL; Franke AE; Gerard RD
    J Biol Chem; 1990 Oct; 265(30):18379-85. PubMed ID: 2120233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1.
    Russell ME; Quertermous T; Declerck PJ; Collen D; Haber E; Homcy CJ
    J Biol Chem; 1990 Feb; 265(5):2569-75. PubMed ID: 2105930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2.
    Owensby DA; Morton PA; Schwartz AL
    J Biol Chem; 1989 Oct; 264(30):18180-7. PubMed ID: 2553701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
    Peraldi MN; Rondeau E; Medcalf RL; Hagège J; Lacave R; Delarue F; Schleuning WD; Sraer JD
    Biochim Biophys Acta; 1992 Apr; 1134(3):189-96. PubMed ID: 1558843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
    J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.